News | November 01, 2023
Ajanta Pharma posts Q2 FY24 consolidated PAT at Rs. 195.30 Cr
Ajanta Pharma has reported total income of Rs. 1049.77 crores during the period ended September 30, 2023
Ajanta Pharma has reported total income of Rs. 1049.77 crores during the period ended September 30, 2023
Dr Reddy’s Laboratories recorded revenue of Rs 6,880.20 crore during the quarter
RPG Life Sciences has reported total income of Rs. 155.41 crores during the period ended September 30, 2023
The company has reported total income of Rs. 486.16 crores during the period ended September 30, 2023
Aarti Drugs has reported total income of Rs. 642.22 crores during the period ended September 30, 2023
Laurus Labs has reported total income of Rs. 1226.23 crores during the period ended September 30, 2023
Profit after tax (before exceptional items) up 23% to Rs 215 crores
NRT offers 50% higher success rate in quitting smoking compared to unassisted attempts
The company has received six final approvals that includes Chlorpromazine Hydrochloride Tablets
JB Pharma reported 19% decrease in GHG intensity as compared to last year and commenced its journey of Scope 3 emissions
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
